Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Every 2 Week Doxil and Gemcitabine in Recurrent Ovarian Cancer
NCT00312650Phase 2Terminated
- Sponsor
- Women & Infants Hospital
- Start
- Apr 2006
- Primary completion
- May 2006
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in ovarian cancer, sponsored by Women & Infants Hospital. Started Apr 2006; status: terminated.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00312650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312650.